Amgen at $478.48: What a Fourth Straight Record Means for Investors
As seen on the 24/7 Wall St. homepage on November 4, 2026.
Amgen just cleared its October 30 record with a $478.48 close, 2.68% above the prior peak and the fourth new high in barely a week. Anyone waiting for a pullback in this biotech hasn't gotten one.
Continue ReadingShow less
Amgen closed at $478.48 on November 4, 2026, landing 2.68% above the prior high set just days earlier on October 30. That margin is a clean extension that confirms buyers remain in control at elevated prices.
Four new highs in barely a week signals that institutional demand is not fading at resistance levels, exactly the pattern that draws in momentum-oriented funds that had been waiting for confirmation before adding exposure.
Sponsored
Amgen spent much of the year consolidating before accelerating sharply in recent months, and the move to the current record is a sustained grind higher rather than a single-day spike.
For investors still on the sidelines, the absence of any meaningful pullback during this run is the central tension. Each new high raises the entry cost and compresses the margin of safety, while that same price action is what makes the trend credible.
Sources
Mentioned: AMGN